Friday 6 November 2026 Export PRAX’s income statement to Excel — free account

Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $8.6 million, up 249.5% from fiscal 2023.

Revenue: +1,349.1%
EPS: +13.3%
Free cash flow: −43.5%

Quarter to June 2026, against a year earlier

276.75 14.16 +5.39%

Follow PRAX

Alert me

Market cap: $7.3B
P/E: 0.0×
Fwd P/E: −24.3×
Dividend yield: —
F-score: n/a
Altman Z: 19.09
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Segments Valuation Filings

Praxis Precision Medicines, Inc. 10-K filed Feb 19, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed Feb 19, 2026 · accepted 8:02 AM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 7, Management’s Discussion and Analysis, against the 10-K filed Feb 28, 2025: 22 added · 19 removed · 47 modified; 3 with only figures updated; 2 moved without change

Praxis Precision Medicines, Inc. 10-K filed Feb 19, 2026

What changed

Stockrow Weekly